SVRA Shareholders Have Opportunity to Lead Savara Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
Summary
Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Savara Inc. and certain of its officers, seeking to recover damages for investors who purchased Savara securities between March 7, 2024, and May 23, 2025. The lawsuit alleges that the company made false and misleading statements regarding its MOLBREEVI BLA, specifically concerning its chemistry, manufacturing, and controls, leading to an unlikely FDA approval. Investors are encouraged to join the case by visiting bgandg.com/SVRA and have until November 7, 2025, to request appointment as lead plaintiff. The firm represents investors on a contingency fee basis, meaning they only receive compensation if a recovery is obtained, and there is no cost to investors to participate. Bronstein, Gewirtz & Grossman, LLC has a history of recovering substantial funds for investors in securities fraud cases.
(Source:WKRN News 2)